PROMETHEUS BIOSCIENCES INC (RXDX)

US74349U1088 - Common Stock

199.92  +0.18 (+0.09%)

After market: 199.95 +0.03 (+0.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
113.34M292.42M257.25M54.20M4.45M
Marketable Securities
600.33M403.33MN/AN/AN/A
Receivables
0.001.03M1.08M1.09M0.00
Other Current Assets
12.73M11.37M7.05M2.17M33.08M
Total Current Assets
726.40M708.15M265.38M57.46M37.53M
 
Non-Current Assets
PPE Net
31.04M31.65M1.45M450.00K320.00K
Intangibles
N/AN/AN/AN/A5.41M
Other Non-Current Assets
971.00K971.00K971.00K1.73M7.22M
Total Non-Current Assets
32.01M32.62M2.42M2.17M12.95M
 
TOTAL ASSETS
758.41M740.77M267.80M59.63M50.48M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/A0.005.68M4.70M
Accrued Expenses
17.03M20.55M11.39M5.62M2.59M
Accounts Payable
1.16M762.00K1.15M960.00K1.40M
Other Current Liabilities
1.15M1.50M3.90M3.01M23.18M
Total Current Liabilities
19.34M22.82M16.44M15.26M31.88M
 
Non-Current Liabilities
Long Term Debt
0.000.000.0011.30M8.34M
Other Non-Current Liabilities
41.46M41.99M16.20M4.60M3.50M
Total Non-Current Liabilities
41.46M41.99M16.20M15.89M11.83M
 
TOTAL LIABILITIES
60.80M64.81M32.65M31.15M43.71M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-371.97M-331.09M-189.34M-99.15M-37.45M
Additional Paid In Capital
1.07B1.01B424.49M1.60M480.00K
Common Shares
5.00K5.00K4.00K126.02M43.74M
Other Shareholders' Equity
-232.00K-429.00KN/AN/AN/A
Shares Outstanding
47.71M46.84M38.94M37.20M37.20M
Tangible Book Value per Share
14.6214.436.04-2.62-1.14
Total Shareholders' Equity
697.62M675.97M235.16M28.48M6.77M
 
TOTAL LIABILITIES AND EQUITY
758.41M740.77M267.80M59.63M50.48M
 
Statistics
Debt/Equity
N/AN/AN/A0.401.23
Current Ratio
37.5631.0416.143.771.18
Return On Assets (ROA)
-19.85%-19.14%-33.68%-62.28%-58.87%
Return On Equity (ROE)
-21.58%-20.97%-38.36%-130.41%-439.00%

All data in USD

Charts